Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger
Recce Pharmaceuticals (ASX:RCE) has been on a tear this year. It's developing anti-infective, R327, with clinical results across Diabetic Foot Infection, Acute Bacterial Skin & Skin Structure Infection, and, Urosepsis/UTIs which point to a potential commercial value proposition. It also has a recent key relationship in Indonesia.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
LMR | Ann: Removal from Official List - COB 1 September 2015 | 28/08/15 | 0 | 1.0K | |||
|
|||||||
LMR | Ann: Suspension from Official Quotation - COB 27/8/15 | 25/08/15 | 0 | 837 | |||
|
|||||||
LMR | Ann: Notice of Compulsory acquisition / Letter to Shareholders | 20/08/15 | 0 | 924 | |||
|
|||||||
LMR | News: Lemur Resources to be compulsorily acquired by Bushveld Minerals | 18/08/15 | 0 | 1.1K | |||
|
|||||||
LMR | Ann: Takeover Offer by Bushveld Minerals -End of Offer Period | 18/08/15 | 0 | 771 | |||
|
|||||||
LMR | Ann: Change in substantial holding | 18/08/15 | 0 | 716 | |||
|
|||||||
LMR | Ann: Acquisition of South African Vanadium Assets | 14/08/15 | 0 | 775 | |||
|
|||||||
LMR | Ann: Notice of Status of Defeating Conditions Under S630(3) | 12/08/15 | 0 | 632 | |||
|
See All Discussions